Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
TIP26-317: A Single-arm, Open-label, Phase II Trial of Cemiplimab Plus Gemcitabine as Second-Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma Harboring SWI/SNF Alterations
Shawn Alaron Abeynaike, Roberta Vezza Alexander, Christina Snider, et al.
European Annals of Allergy and Clinical Immunology
|
October 30, 2025
Small airway dysfunction in asthma: concordance and discordance between spirometry and oscillometry in real-life
A Botta, C P Ratti, A Chiei Gallo, et al.
American Journal of Cancer Research
|
August 10, 2023
Challenges and prospects of CSF1R targeting for advanced malignancies
Ann Moeller, Razelle Kurzrock, Gregory P Botta, et al.
The Oncologist
|
December 23, 2022
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma
Georges Azzi, Mehrad Tavallai, Vasily N Aushev, et al.
Nature Communications
|
March 22, 2021
Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
Tatiana Hurtado de Mendoza, Evangeline S Mose, Gregory P Botta, et al.
ESMO Open
|
March 19, 2024
Viewing the immune checkpoint VISTA: landscape and outcomes across cancers
D Nishizaki, R Kurzrock, H Miyashita, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to <i>KRAS</i> mutational status
E B Faber, Y Baca, J Xiu, et al.
Journal for Immunotherapy of Cancer
|
February 5, 2024
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells
Gregory P Botta, Joseph Chao, Hong Ma, et al.
JCO Precision Oncology
|
December 8, 2022
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers
Brandon M Huffman, Vasily N Aushev, Griffin L Budde, et al.
The Oncologist
|
July 18, 2024
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
Gregory P Botta, Maen Abdelrahim, Ronald L Drengler, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 30, 2026
TIP26-317: A Single-arm, Open-label, Phase II Trial of Cemiplimab Plus Gemcitabine as Second-Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma Harboring SWI/SNF Alterations
Shawn Alaron Abeynaike, Roberta Vezza Alexander, Christina Snider, et al.
European Annals of Allergy and Clinical Immunology
|
October 30, 2025
Small airway dysfunction in asthma: concordance and discordance between spirometry and oscillometry in real-life
A Botta, C P Ratti, A Chiei Gallo, et al.
American Journal of Cancer Research
|
August 10, 2023
Challenges and prospects of CSF1R targeting for advanced malignancies
Ann Moeller, Razelle Kurzrock, Gregory P Botta, et al.
The Oncologist
|
December 23, 2022
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma
Georges Azzi, Mehrad Tavallai, Vasily N Aushev, et al.
Nature Communications
|
March 22, 2021
Tumor-penetrating therapy for β5 integrin-rich pancreas cancer
Tatiana Hurtado de Mendoza, Evangeline S Mose, Gregory P Botta, et al.
ESMO Open
|
March 19, 2024
Viewing the immune checkpoint VISTA: landscape and outcomes across cancers
D Nishizaki, R Kurzrock, H Miyashita, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to <i>KRAS</i> mutational status
E B Faber, Y Baca, J Xiu, et al.
Journal for Immunotherapy of Cancer
|
February 5, 2024
Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells
Gregory P Botta, Joseph Chao, Hong Ma, et al.
JCO Precision Oncology
|
December 8, 2022
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers
Brandon M Huffman, Vasily N Aushev, Griffin L Budde, et al.
The Oncologist
|
July 18, 2024
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma
Gregory P Botta, Maen Abdelrahim, Ronald L Drengler, et al.
Page
of 4